The current study aimed to investigate the clinical impact of the genetic polymorphisms MECP2 rs2734647and TIRAP rs8177374 on the clinical outcomes and selective management of SLE with or without nephritis. This evidence concerns the gene MECP2 and systemic lupus erythematosus.